The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological Malignancies Academic Article uri icon

Overview

MeSH Major

  • Cord Blood Stem Cell Transplantation
  • Hematologic Neoplasms
  • Melphalan
  • Myeloablative Agonists
  • Radiation Dosage
  • Transplantation Conditioning
  • Vidarabine
  • Whole-Body Irradiation

abstract

  • Overall, combination fludarabine-melphalan with low dose TBI after haplo-cord SCT assures good engraftment and leads to acceptable toxicity and disease control in the setting of high risk, heavily pretreated patients. These findings warrant further investigation at a larger-scale, prospective level.

publication date

  • October 19, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/TP.0000000000001538

PubMed ID

  • 27764032

Additional Document Info